Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03286439
Other study ID # NA-1-2017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 13, 2017
Est. completion date July 6, 2018

Study information

Verified date September 2018
Source Zealand University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to investigate the in-hospital care as well as the cognitive status, quality of life, physical function and risk of anxiety and depression, sleep disorders and drug use in a Danish cohort of both medical and surgical patients with acute critical illness without admittance to ICU (Intensive Care Unit) treatment, at three and twelve months after hospital discharge.


Description:

A stay at the ICU (intensive Care Unit) is related to life-threatening conditions and often displays a major impact on both physical and mental resources of the patients. Studies show that a great part of ICU patients have impairments of both physical and psychological kinds, some long-lasting. This condition is termed the "post intensive care syndrome" (PICS) and describes a wide range of symptoms as fatigue, depression, anxiety, memory loss along with both cognitive and physical impairments. Rehabilitative efforts are, thus, needed, and it has been suggested that ideally, rehabilitation should begin at the time of admission to the hospital and continue for a long time, possibly years, after the patient has been discharged. Regarding long term cognitive function of the ICU survivors in particular, recent studies have demonstrated severe impairment at the level of light Alzheimer's disease. In all of these studies, the reference group is the normal population, and it is a general problem that the cognitive and physical function of ICU patients before critical illness is unknown. There has recently been a norwegian study that included a reference group of surgical patients undergoing major surgery. The surgical group was older and more severely ill than the ICU group and was found to have a much worse cognitive function. Moreover, the cognitive function of the critically ill patients was not very far from the normal reference population due to selection.

To determine to which degree the impairments can be attributed to ICU-admission, the investigators need to look at a hospitalised and representative, non-ICU population, which is what will be done in the study. The investigators will therefore include patients that have been admitted to surgical or medical department acute without admittance to the ICU and contact these patients 3 and 12 months after admission. Where there will be performed different tests in order to evaluate the the cognitive status, quality of life, physical function and risk of anxiety and depression, sleep disorders and drug use.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date July 6, 2018
Est. primary completion date July 6, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients > 18 years of age

- Admitted to surgical or medical department > 3 days

- Admitted with one of the following diagnoses:

- Pneumonia

- Heart failure

- Pulmonary embolism

- Acute myocardial infarction

- Pyelonephritis

- Patients undergoing non-elective open or laparoscopic abdominal surgery (not including elective procedures, diseases of the appendix, diseases of the gallbladder, liver, spleen, kidney, pancreas and emergency hernia surgery without bowel resection)

Exclusion Criteria:

- Permanently incompetent patients not able to consent

- Not able to speak and understand Danish

- Discharged from the hospital for terminal care

- Patients transferred to another hospital during the stay

- Patients living outside the Region of Zealand

- Patients admitted under duress or actively psychotic

- Patients that are blind or severely visually impaired.

Study Design


Intervention

Other:
there will be offered a follow up visit
The investigators will offer the patients a follow up visit 3 and 12 months after discharge from the hospital.

Locations

Country Name City State
Denmark Zealand University Hospital Køge

Sponsors (1)

Lead Sponsor Collaborator
Zealand University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cognitive function Cognitive Function measured by The Repeatable Battery for The Assesment of Neuropsychological Status (RBANS) 3 months after discharge
Secondary Cognitive function after one year Cognitive function measured with The Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) evaluation at 12 months after discharge from hospital 12 months after discharge
Secondary Rehabilitation after 3 months This will be investigated by filling out a checklist of community support and contact to health care system at 3 month follow up 3 months after discharge
Secondary Self-reported health related quality of life This will be investigated by filling out a questionnaire named SF 36, Short Form Health Survey. 3 months after discharge
Secondary Self-reported health related quality of life This will be investigated by filling out a questionnaire named SF 36, Short Form Health Survey. 12 months after discharge
Secondary Objective assessment of physical function This will be investigated by filling out a checklist called CPAx, The Chelsea Critical Care Physical Assessment Tool. 3 months after discharge
Secondary Objective assessment of physical function This will be investigated by filling out a checklist called CPAx, The Chelsea Critical Care Physical Assessment Tool 12 months after discharge
Secondary Mortality The mortality of the patients within 90 days after hospital discharge. 90 days after discharge
Secondary Consumption of opioids Percentage of patients with a daily consumption of opioids at hospital admission and 90 days after discharge 90 days after discharge
Secondary Consumption of statins days after discharge Percentage of patients with a daily consumption of statins at hospital admission and at 90 days after discharge 90 days after discharge
Secondary Consumption of anti-depressants Percentage of patients with a daily consumption of anti-depressants at hospital admission and at 90 days after discharge 90 days after discharge
Secondary Sleepiness This will be investigated by filling out Epworth Sleepiness Scale At inclusion
Secondary Sleepiness This will be investigated by filling out Epworth Sleepiness Scale 3 months after discharge
Secondary Sleepiness This will be investigated by filling out Epworth Sleepiness Scale 12 months after discharge
Secondary Insomnia This will be investigated by filling out Insomnia Severity Index At inclusion
Secondary Insomnia This will be investigated by filling out Insomnia Severity Index 3 months after discharge
Secondary Insomnia This will be investigated by filling out Insomnia Severity Index 12 months after discharge
Secondary Sleep Quality This will be investigated by filling out Pittsburgh Sleep Quality Index At inclusion
Secondary Sleep Quality This will be investigated by filling out Pittsburgh Sleep Quality Index 3 months after discharge
Secondary Sleep Quality This will be investigated by filling out Pittsburgh Sleep Quality Index 12 months after discharge
Secondary Information processing speed This will be investigated by filling out the Trail Making Test Part A 3 months after discharge
Secondary Information processing speed This will be investigated by filling out the Trail Making Test Part A 12 months after discharge
Secondary Executive function This will be investigated by filling out the Trail Making Test Part B 3 months after discharge
Secondary Executive function This will be investigated by filling out the Trail Making Test Part B 12 months after discharge
Secondary Rehabilitation after 12 months This will be investigated by filling out a checklist of Community support and contact to health care system at 3 month follow up 12 months
Secondary Consumption of sleep medication Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge At inclusion
Secondary Consumption of sleep medication Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge 90 days after discharge
Secondary Consumption of sleep medication Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge 12 months after discharge
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04961112 - Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits N/A
Completed NCT03695614 - Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia N/A
Active, not recruiting NCT05879562 - Validation of a Digital Self-Administered Cognitive Screening Tool: MoCA-XpressO N/A
Recruiting NCT04251624 - Investigating the Use of Goal Management Therapy in Improving Cognitive Functioning in Public Safety Personnel With PTSD N/A
Not yet recruiting NCT02763397 - Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease N/A
Recruiting NCT04051528 - Do Combinatorial Training Lead to Better Cognition and Daily Participation in TBI Persons With Cognitive Impairments N/A
Recruiting NCT03036319 - Patient-Centered NeuroRehabilitation (PCN) N/A
Recruiting NCT05251454 - Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects. N/A
Completed NCT05063669 - Cognitive Intervention in Attention Deficit and Hyperactivity Disorder N/A
Completed NCT02964221 - Cognitive Changes After Major Joint Replacement N/A
Not yet recruiting NCT05605366 - Minocycline In Neurocognitive Outcomes - Sickle Cell Disease Phase 1
Completed NCT02214342 - Virtual Reality Based Balance Training in People With Mild Cognitive Impairment N/A
Terminated NCT03032471 - Swiss SOS MoCA - DCI Study
Recruiting NCT04456777 - Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia Early Phase 1
Recruiting NCT04204239 - Validation Study SCOBES-AR
Withdrawn NCT04457271 - Goal Management Training in Individuals With PTSD N/A
Terminated NCT03034109 - Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits N/A
Recruiting NCT05802680 - Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation N/A
Active, not recruiting NCT02847403 - Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients Phase 3
Withdrawn NCT04654130 - Neurofeedback Effectiveness Trial in PTSD N/A